NovaMechanics Ltd

NovaMechanics Ltd is an in silico drug design company established in 2007. It is dedicated to the computer-aided design of small molecules for various target classes with a focus on the development and implementation of in silico methods for guiding decisions in the design and selection of promising drug candidates. The company leverages its industry-recognized expertise, state-of-the-art software, and proprietary computing infrastructure to provide advanced in silico capabilities in molecular design and simulation. NovaMechanics' mission is to bridge the gap between disease targets and high-quality drug candidates while lowering costs and increasing potential revenues for collaborators in the Analytics, Biotechnology, and Clean Energy industries. NovaMechanics Ltd offers bespoke in silico drug design and discovery products and services centered on high-throughput computational techniques. Its algorithms rapidly convert ligand information or protein structure information into new chemical designs, maximizing the value within the research portfolio of pharmaceutical partners. Additionally, the company's research team has experience in a range of computer-aided drug design (CADD) techniques, including protein and ligand modeling, structure-based design methods, chemoinformatics for data management, and ADMET and PBPK models. With a commitment to chemistry-driven projects and CADD technology, NovaMechanics is poised to make significant contributions to the pharmaceutical industry.